1. Home
  2. SRI vs MDXH Comparison

SRI vs MDXH Comparison

Compare SRI & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

N/A

Current Price

$8.00

Market Cap

161.7M

ML Signal

N/A

Logo MDxHealth SA

MDXH

MDxHealth SA

N/A

Current Price

$3.52

Market Cap

183.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SRI
MDXH
Founded
1965
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
161.7M
183.4M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
SRI
MDXH
Price
$8.00
$3.52
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$16.00
$7.67
AVG Volume (30 Days)
193.1K
90.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$824,444,000.00
N/A
Revenue This Year
N/A
$23.34
Revenue Next Year
$6.43
$22.98
P/E Ratio
N/A
N/A
Revenue Growth
18.46
N/A
52 Week Low
$3.54
$1.35
52 Week High
$9.71
$5.33

Technical Indicators

Market Signals
Indicator
SRI
MDXH
Relative Strength Index (RSI) 52.38 49.82
Support Level $6.61 $3.05
Resistance Level $8.79 $3.78
Average True Range (ATR) 0.54 0.18
MACD -0.12 0.00
Stochastic Oscillator 20.52 42.50

Price Performance

Historical Comparison
SRI
MDXH

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: